Acupuncture combined with repetitive transcranial magnetic stimulation for post-stroke depression: a randomized controlled trial.
10.13703/j.0255-2930.20211221-0002
- Author:
Zheng-Lu YIN
1
;
Sheng GE
1
;
Ling-Hui HUANG
1
;
Xing-Xing CAO
1
;
Jia-Hao WU
1
Author Information
1. Department of Rehabilitation, Subei People's Hospital, Clinical Medical College of Yangzhou University, Yangzhou 225002, Jiangsu Province, China.
- Publication Type:Journal Article
- Keywords:
5-hydroxytryptamine (5-HT);
acupuncture;
brain-derived neurotrophic factor (BDNF);
post-stroke depression;
repetitive transcranial magnetic stimulation (rTMS)
- MeSH:
Humans;
Transcranial Magnetic Stimulation;
Brain-Derived Neurotrophic Factor;
Depression/therapy*;
Serotonin;
Treatment Outcome;
Acupuncture Therapy;
Stroke/psychology*
- From:
Chinese Acupuncture & Moxibustion
2022;42(11):1216-1220
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the curative effect of Shugan Tiaoshen (soothing liver and regulating mind) acupuncture combined with repetitive transcranial magnetic stimulation (rTMS) in the treatment of post-stroke depression (PSD), and to explore its mechanism.
METHODS:Ninety patients of PSD were randomly divided into an acupuncture+rTMS combination group (30 cases), a rTMS combination group (30 cases, 1 case dropped off) and a western medication group (30 cases, 1 case dropped off). The western medication group was treated with escitalopram oxalate tablets, 10 mg orally each time, once a day; on the basis of the treatment in the western medication group, the rTMS combination group was additionally given rTMS, and the frequency was 20 Hz, 20 min each time, once a day, 5 times a week; on the basis of the treatment in the rTMS combination group, the acupuncture+rTMS combination group was additionally treated with Shugan Tiaoshen acupuncture at Baihui (GV 20), Sishencong (EX-HN 1), Yintang (GV 24+), Shenting (GV 24), etc. for 40 min each time, once a day, weekly 5 times, and each group was treated for 4 weeks. Before and after treatment, the scores of Hamilton depression scale-17 (HAMD-17), Montreal cognitive assessment scale (MoCA), Pittsburgh sleep quality index (PSQI) were observed, and serum levels of 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF) were detected in each group.
RESULTS:After treatment, the HAMD-17 scores in the three groups were lower than those before treatment (P<0.01), and the PSQI scores in the acupuncture+rTMS combination group and the rTMS combination group were lower than those before treatment (P<0.01); the above indexes in the acupuncture+rTMS combination group and the rTMS combination group were lower than those in the western medication group (P<0.05), and the PSQI score in the acupuncture+rTMS combination group was lower than that in the rTMS combination group (P<0.05). After treatment, the MoCA scores and serum BDNF levels in the acupuncture+rTMS combination group and the rTMS combination group were higher than those before treatment (P<0.01), and the serum 5-HT levels in the three groups were higher than those before treatment (P<0.01); and the above indexes in the acupuncture+rTMS combination group and the rTMS combination group were higher than those in the western medication group (P<0.05), and which in the acupuncture+rTMS combination group were higher than those in the rTMS combination group (P<0.05).
CONCLUSION:On the basis of western medication escitalopram oxalate, the addition of Shugan Tiaoshen acupuncture combined with rTMS therapy can effectively improve cognitive function and sleep quality in patients with PSD, and the effect is better than that of western medication alone or rTMS combined with western medication. Its mechanism of action may be related to the increase of peripheral serum 5-HT and BDNF levels.
